Non-invasive pre-implantation genetic diagnosis of X-linked disorders

Medical Hypotheses

Volumn 83, Issue 4, 2014, Pages 506-508

  Assou, Said ^a,b   Aït Ahmed, Ounissa ^a,b   El Messaoudi, Safia ^c   Thierry, Alain R ^c   Hamamah, Samir ^a,b,d  

^a UNIV MONTPELLIER   (France)

^b HÔPITAL SAINT ELOI   (France)

^c INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

^d HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; NUCLEIC ACID;

ARTICLE; BIOPSY; CELL FREE SYSTEM; CULTURE MEDIUM; EMBRYO; EMBRYO CELL; EMBRYO CULTURE; FEMALE; FERTILIZATION IN VITRO; GENETIC SCREENING; HUMAN; MALE; MOLECULAR DIAGNOSIS; NON INVASIVE PROCEDURE; NUCLEOTIDE SEQUENCE; PREIMPLANTATION GENETIC DIAGNOSIS; PRENATAL DIAGNOSIS; SEX DIFFERENCE; X CHROMOSOME; X CHROMOSOME LINKED DISORDER; Y CHROMOSOME; GENETIC DISEASES, X-LINKED; PROCEDURES; THEORETICAL MODEL;

GENETIC DISEASES, X-LINKED; HUMANS; MODELS, THEORETICAL; PREIMPLANTATION DIAGNOSIS;

EID: 84923926670     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2014.08.019     Document Type: Article

References (13)

1. Sermon K., Van Steirteghem A., Liebaers I. Preimplantation genetic diagnosis. Lancet 2004, 363:1633-1641.
2. Kirkegaard K., Hindkjaer J.J., Ingerslev H.J. Human embryonic development after blastomere removal: a time-lapse analysis. Hum Reprod 2012, 27:97-105.
3. Lo Y.M., Corbetta N., Chamberlain P.F., et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997, 350:485-487.
4. Traver S., Assou S., Scalici E., et al. Cell-free nucleic acids as non-invasive biomarkers of gynecological cancers, ovarian, endometrial and obstetric disorders and fetal aneuploidy. Hum Reprod Update 2014.
5. Palini S., Galluzzi L., De Stefani S., et al. Genomic DNA in human blastocoele fluid. Reprod Biomed Online 2013, 26:603-610.
6. Thierry A.R., Mouliere F., El Messaoudi S., et al. Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA. Nat Med 2014, 20:430-435.
7. Stigliani S., Anserini P., Venturini P.L., Scaruffi P. Mitochondrial DNA content in embryo culture medium is significantly associated with human embryo fragmentation. Hum Reprod 2013, 28:2652-2660.
8. Miura K., Higashijima A., Shimada T., et al. Clinical application of fetal sex determination using cell-free fetal DNA in pregnant carriers of X-linked genetic disorders. J Hum Genet 2011, 56:296-299.
9. Tsui N.B., Kadir R.A., Chan K.C., et al. Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA. Blood 2011, 117:3684-3691.
10. Lavery S. Preimplantation genetic diagnosis of haemophilia. Br J Haematol 2009, 144:303-307.
11. Romao R.M., Levi J.E., Carvalho H.B., et al. Use of cell-free fetal nucleic acids in maternal blood for prenatal diagnosis: the reality of this scenario in Brazil. Rev Assoc Med Bras 2012, 58:615-619.
12. Thierry A.R., Mouliere F., Gongora C., et al. Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts. Nucleic Acids Res 2010, 38:6159-6175.
13. Dawson S.J., Tsui D.W., Murtaza M., et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med 2013, 368:1199-1209.